Clive Robertson
Family · Bedford, NHNPI 1710655006
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,284 of the $7,421 with a category attached, or 84.7%. 32 manufacturers reported payments, led by Boston Scientific at 29.0% of the total. Reporting peaked in 2022 at $2,515 and has fallen 60.4% since, to $996 in 2025. Among family clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$963
- Collegium Pharmaceutical, Inc.$394
- Johnson & Johnson$330
- Teva Pharmaceuticals USA, Inc.$260
- plus $2K from 26 others
What the payments were for
- Travel & lodging$1,13715%
- Food & beverage$6,28485%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 30 | $2,156 |
| AbbVie(2 entities) | 68 | $1,473 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 65 | $963 |
| Collegium Pharmaceutical, Inc. | 32 | $394 |
| Johnson & Johnson | 12 | $330 |
| Teva Pharmaceuticals USA, Inc. | 12 | $260 |
| Lundbeck LLC | 12 | $220 |
| Valinor Pharma, LLC | 14 | $189 |
| Pfizer | 9 | $183 |
| Ultragenyx Pharmaceutical Inc. | 6 | $149 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $135 |
| GRT US Holding, Inc. | 7 | $117 |
| Painteq LLC | 3 | $112 |
| IBSA Pharma Inc. | 4 | $93 |
| Amgen | 4 | $85 |
| Redhill Biopharma Inc. | 4 | $76 |
| Si-bone, Inc. | 1 | $56 |
| Kyowa Kirin, Inc. | 2 | $55 |
| Merz Pharmaceuticals, LLC | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Vertex | 2 | $35 |
| Stimwave Technologies Incorporated | 1 | $27 |
| Spinal Simplicity, LLC | 1 | $27 |
| Globus Medical | 1 | $25 |
| Averitas Pharma Inc. | 1 | $23 |
| Relievant Medsystems, Inc. | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,421 in reported general payments places this provider in the 95th percentile of 713 family providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 31 | $21,622 |
| Nurtec OdtRimegepant Sulfate | 11 | $17,824 |
| BotoxOnabotulinumtoxina | 14 | $17,372 |
| Buprenorphine | 59 | $14,529 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 53 | $7,600 |
| Tizanidine Hcl | 343 | $7,435 |
| LinzessLinaclotide | 13 | $6,898 |
| Xtampza ErOxycodone Myristate | 18 | $6,057 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 220 | $5,128 |
| Oxycodone Hcl | 276 | $4,808 |
| Gabapentin | 261 | $4,104 |
| Morphine Sulfate ErMorphine Sulfate | 91 | $2,686 |
| Pregabalin | 146 | $2,658 |
| OxycontinOxycodone Hcl | 13 | $2,141 |
| Tramadol Hcl | 133 | $2,029 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $394 | $27,67949 claims |
| AbbVieBotox, Linzess | $1,473 | $24,26927 claims |
| PfizerNurtec Odt | $183 | $17,82411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 713 family providers in New Hampshire.
Other family in Bedford
- Michelle WhiteBedford$9K
- Lynne DuganBedford$2K
- Tara Delle ChiaieHampton$548K
- Wendy WrightAmherst$447K
- Richard CareyNashua$51K
- Summer BellDerry$16K
- Laura HudsonDover$14K
- Debra KrisonNorth Hampton$13K
- Brant OliverConcord$9K
- Cassandra CavanaughDover$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.